EPHA2 activates AMPK signaling via the ligand Ephrin A1-dependent forward pathway to promote the tube-forming and migration ability of endothelial cells, thereby promoting breast cancer metastasis (Figure 8). This evidence concerns the gene EPHA2 and breast cancer.